{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:20:22Z","timestamp":1772025622016,"version":"3.50.1"},"reference-count":51,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0105","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T09:34:28Z","timestamp":1645004068000},"source":"Crossref","is-referenced-by-count":6,"title":["Genetic predisposition and the variable course of infectious diseases"],"prefix":"10.3238","author":[{"given":"Axel","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Groh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia S.","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin U.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"10.3238\/arztebl.m2022.0105_ref1","doi-asserted-by":"crossref","unstructured":"Shelton JF, Shastri AJ, Ye C, et al.: Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nat Genet 2021; 53: 801&#8211;8.","DOI":"10.1038\/s41588-021-00854-7"},{"key":"10.3238\/arztebl.m2022.0105_ref2","doi-asserted-by":"crossref","unstructured":"Barua D, Paguio AS: ABO blood groups and cholera. Ann Hum Biol 1977; 4: 489&#8211;92.","DOI":"10.1080\/03014467700002481"},{"key":"10.3238\/arztebl.m2022.0105_ref3","doi-asserted-by":"crossref","unstructured":"S\u00f8rensen TI, Nielsen GG, Andersen PK, Teasdale TW: Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318: 727&#8211;32.","DOI":"10.1056\/NEJM198803243181202"},{"key":"10.3238\/arztebl.m2022.0105_ref4","doi-asserted-by":"crossref","unstructured":"Williams FMK, Freidin MB, Mangino M, et al.: Self-reported symptoms of COVID-19, including symptoms most predictive of SARS-CoV-2 infection, are heritable. Twin Res Hum Genet 2020; 23: 316&#8211;21.","DOI":"10.1017\/thg.2020.85"},{"key":"10.3238\/arztebl.m2022.0105_ref5","doi-asserted-by":"crossref","unstructured":"Hedrick PW: Population genetics of malaria resistance in humans. Heredity (Edinb) 2011; 107: 283&#8211;304.","DOI":"10.1038\/hdy.2011.16"},{"key":"10.3238\/arztebl.m2022.0105_ref6","doi-asserted-by":"crossref","unstructured":"Khera AV, Chaffin M, Aragam KG, et al.: Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet 2018; 50: 1219&#8211;24.","DOI":"10.1038\/s41588-018-0183-z"},{"key":"10.3238\/arztebl.m2022.0105_ref7","doi-asserted-by":"crossref","unstructured":"Loos RJF: 15 years of genome-wide association studies and no signs of slowing down. Nat Commun 2020; 11: 5900.","DOI":"10.1038\/s41467-020-19653-5"},{"key":"10.3238\/arztebl.m2022.0105_ref8","doi-asserted-by":"crossref","unstructured":"Tian C, Hromatka BS, Kiefer AK, et al.: Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections. Nat Commun 2017; 8: 599.","DOI":"10.1038\/s41467-017-00257-5"},{"key":"10.3238\/arztebl.m2022.0105_ref9","doi-asserted-by":"crossref","unstructured":"Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL: Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol 2014; 26: 454&#8211;70.","DOI":"10.1016\/j.smim.2014.09.008"},{"key":"10.3238\/arztebl.m2022.0105_ref10","doi-asserted-by":"crossref","unstructured":"Farmand S, Baumann U, von Bernuth H, et al.: [Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency]. Klin Padiatr 2011; 223: 378&#8211;85.","DOI":"10.1055\/s-0031-1287835"},{"key":"10.3238\/arztebl.m2022.0105_ref11","doi-asserted-by":"crossref","unstructured":"Hanitsch L, Baumann U, Boztug K, et al.: Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline. Eur J Immunol 2020; 50: 1432&#8211;46.","DOI":"10.1002\/eji.202048713"},{"key":"10.3238\/arztebl.m2022.0105_ref12","doi-asserted-by":"crossref","unstructured":"Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL: Innate and adaptive immune memory: an evolutionary continuum in the host&#8217;s response to pathogens. Cell Host Microbe 2019; 25: 13&#8211;26.","DOI":"10.1016\/j.chom.2018.12.006"},{"key":"10.3238\/arztebl.m2022.0105_ref13","doi-asserted-by":"crossref","unstructured":"Takeda K, Kaisho T, Akira S: Toll-like receptors. Annu Rev Immunol 2003; 21: 335&#8211;76.","DOI":"10.1146\/annurev.immunol.21.120601.141126"},{"key":"10.3238\/arztebl.m2022.0105_ref14","unstructured":"Lim HK, Huang SXL, Chen J, et al.: Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med 2019; 216: 2038&#8211;56."},{"key":"10.3238\/arztebl.m2022.0105_ref15","doi-asserted-by":"crossref","unstructured":"Garcia-Etxebarria K, Bracho MA, Gal\u00e1n JC, et al.: No major host genetic risk factor contributed to A(H1N1)2009 influenza severity. PloS One 2015; 10: e0135983.","DOI":"10.1371\/journal.pone.0135983"},{"key":"10.3238\/arztebl.m2022.0105_ref16","doi-asserted-by":"crossref","unstructured":"Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367&#8211;77.","DOI":"10.1016\/S0092-8674(00)80110-5"},{"key":"10.3238\/arztebl.m2022.0105_ref17","doi-asserted-by":"crossref","unstructured":"H\u00fctter G, Nowak D, Mossner M, et al.: Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation. N Engl J Med 2009; 360: 692&#8211;8.","DOI":"10.1056\/NEJMoa0802905"},{"key":"10.3238\/arztebl.m2022.0105_ref18","doi-asserted-by":"crossref","unstructured":"McLaren PJ, Pulit SL, Gurdasani D, et al.: Evaluating the impact of functional genetic variation on HIV-1 control. J Infect Dis 2017; 216: 1063&#8211;9.","DOI":"10.1093\/infdis\/jix470"},{"key":"10.3238\/arztebl.m2022.0105_ref19","doi-asserted-by":"crossref","unstructured":"Kulkarni S, Lied A, Kulkarni V, et al.: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. Nat Immunol 2019; 20: 824&#8211;34.","DOI":"10.1038\/s41590-019-0406-1"},{"key":"10.3238\/arztebl.m2022.0105_ref20","doi-asserted-by":"crossref","unstructured":"McLaren PJ, Coulonges C, Bartha I, et al.: Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A 2015; 112: 14658&#8211;63.","DOI":"10.1073\/pnas.1514867112"},{"key":"10.3238\/arztebl.m2022.0105_ref21","unstructured":"Apps R, Qi Y, Carlson JM, et al.: Influence of HLA-C expression level on HIV control. Science 2013; 340: 87&#8211;91."},{"key":"10.3238\/arztebl.m2022.0105_ref22","doi-asserted-by":"crossref","unstructured":"Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283: 1748&#8211;52.","DOI":"10.1126\/science.283.5408.1748"},{"key":"10.3238\/arztebl.m2022.0105_ref23","doi-asserted-by":"crossref","unstructured":"Mallal S, Nolan D, Witt C, et al.: Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359: 727&#8211;32.","DOI":"10.1016\/S0140-6736(02)07873-X"},{"key":"10.3238\/arztebl.m2022.0105_ref24","doi-asserted-by":"crossref","unstructured":"Illing PT, Vivian JP, Dudek NL, et al.: Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 2012; 486: 554&#8211;8.","DOI":"10.1038\/nature11147"},{"key":"10.3238\/arztebl.m2022.0105_ref25","doi-asserted-by":"crossref","unstructured":"Blum JS, Wearsch PA, Cresswell P: Pathways of antigen processing. Annu Rev Immunol 2013; 31: 443&#8211;73.","DOI":"10.1146\/annurev-immunol-032712-095910"},{"key":"10.3238\/arztebl.m2022.0105_ref26","doi-asserted-by":"crossref","unstructured":"Rosain J, Kong XF, Martinez-Barricarte R, et al.: Mendelian susceptibility to mycobacterial disease: 2014&#8211;2018 update. Immunol Cell Biol 2019; 97: 360&#8211;7.","DOI":"10.1111\/imcb.12210"},{"key":"10.3238\/arztebl.m2022.0105_ref27","unstructured":"COVID-19 Host Genetics Initiative: Mapping the human genetic architecture of COVID-19. Nature 2021; 600: 472&#8211;7."},{"key":"10.3238\/arztebl.m2022.0105_ref28","doi-asserted-by":"crossref","unstructured":"Severe Covid GG, Ellinghaus D, Degenhardt F, et al.: Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med 2020; 383: 1522&#8211;34.","DOI":"10.1056\/NEJMoa2020283"},{"key":"10.3238\/arztebl.m2022.0105_ref29","doi-asserted-by":"crossref","unstructured":"Nakanishi T, Pigazzini S, Degenhardt F, et al.: Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest 2021; 131.","DOI":"10.1101\/2021.03.07.21252875"},{"key":"10.3238\/arztebl.m2022.0105_ref30","doi-asserted-by":"crossref","unstructured":"van der Made CI, Simons A, Schuurs-Hoeijmakers J, et al.: Presence of genetic variants among young men with severe COVID-19. JAMA 2020; 324: 663&#8211;73.","DOI":"10.1001\/jama.2020.13719"},{"key":"10.3238\/arztebl.m2022.0105_ref31","unstructured":"Asano T, Boisson B, Onodi F, et al.: X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19. Sci Immunol 2021; 6."},{"key":"10.3238\/arztebl.m2022.0105_ref32","doi-asserted-by":"crossref","unstructured":"Solanich X, Vargas-Parra G, van der Made CI, et al.: Genetic screening for TLR7 variants in young and previously healthy men with severe COVID-19. Front Immunol 2021; 12: 719115.","DOI":"10.3389\/fimmu.2021.719115"},{"key":"10.3238\/arztebl.m2022.0105_ref33","doi-asserted-by":"crossref","unstructured":"Schmidt A, Peters S, Knaus A, et al.: TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19. NPJ Genom Med 2021; 6: 55.","DOI":"10.1038\/s41525-021-00220-w"},{"key":"10.3238\/arztebl.m2022.0105_ref34","doi-asserted-by":"crossref","unstructured":"L\u00e9vy R, Bastard P, Lanternier F, Lecuit M, Zhang SY, Casanova JL: IFN-&#945;2a therapy in two patients with inborn errors of TLR3 and IRF3 infected with SARS-CoV-2. J Clin Immunol 2021; 41: 26&#8211;7.","DOI":"10.1007\/s10875-020-00933-0"},{"key":"10.3238\/arztebl.m2022.0105_ref35","doi-asserted-by":"crossref","unstructured":"Nelson MR, Tipney H, Painter JL, et al.: The support of human genetic evidence for approved drug indications. Nat Genet 2015; 47: 856&#8211;60.","DOI":"10.1038\/ng.3314"},{"key":"10.3238\/arztebl.m2022.0105_ref36","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Nishida N, Sugiyama M, et al.: Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 2009; 41: 1105&#8211;9.","DOI":"10.1038\/ng.449"},{"key":"10.3238\/arztebl.m2022.0105_ref37","doi-asserted-by":"crossref","unstructured":"Bloomfield M, Kanderova V, Parackova Z, et al.: Utility of Ruxolitinib in a child with chronic mucocutaneous Ccandidiasis caused by a novel&nbsp;STAT1 gain-of-function mutation. J Clin Immunol 2018; 38: 589&#8211;601.","DOI":"10.1007\/s10875-018-0519-6"},{"key":"10.3238\/arztebl.m2022.0105_ref38","doi-asserted-by":"crossref","unstructured":"Becker K, Hu Y, Biller-Andorno N: Infectious diseases&#8212;a global challenge. Int J Med Microbiol 2006; 296: 179&#8211;85.","DOI":"10.1016\/j.ijmm.2005.12.015"},{"key":"10.3238\/arztebl.m2022.0105_ref39","doi-asserted-by":"crossref","unstructured":"Casanova JL, Abel L: Lethal infectious diseases as inborn errors of immunity: toward a synthesis of the germ and genetic theories. Annu Rev Pathol 2021; 16: 23&#8211;50.","DOI":"10.1146\/annurev-pathol-031920-101429"},{"key":"10.3238\/arztebl.m2022.0105_ref40","doi-asserted-by":"crossref","unstructured":"Kwok AJ, Mentzer A, Knight JC: Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet 2021; 22: 137&#8211;53.","DOI":"10.1038\/s41576-020-00297-6"},{"key":"10.3238\/arztebl.m2022.0105_ref41","doi-asserted-by":"crossref","unstructured":"Cassini A, Colzani E, Pini A, et al.: Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the burden of communicable diseases in Europe study, European Union and European economic area countries, 2009 to 2013. Euro Surveill 2018; 23.","DOI":"10.2807\/1560-7917.ES.2018.23.16.17-00454"},{"key":"10.3238\/arztebl.m2022.0105_ref42","doi-asserted-by":"crossref","unstructured":"Rommel A, Lippe EV, Plass D, et al.: The COVID-19 disease burden in Germany in 2020-years of life lost to death and disease over the course of the pandemic. Dtsch Arztebl Int 2021; 118.","DOI":"10.3238\/arztebl.m2021.0147"},{"key":"10.3238\/arztebl.m2022.0105_ref43","doi-asserted-by":"crossref","unstructured":"Sologuren I, Mart\u00ednez-Saavedra MT, Sol\u00e9-Violan J, et al.: Lethal influenza in two related adults with inherited GATA2 deficiency. J Clin Immunol 2018; 38: 513&#8211;26.","DOI":"10.1007\/s10875-018-0512-0"},{"key":"10.3238\/arztebl.m2022.0105_ref44","unstructured":"Zhang SY, Clark NE, Freije CA, et al.: Inborn errors of RNA lariat metabolism in humans with brainstem viral infection. Cell 2018; 172: 952&#8211;65 e18."},{"key":"10.3238\/arztebl.m2022.0105_ref45","doi-asserted-by":"crossref","unstructured":"Gupta RK, Abdul-Jawad S, McCoy LE, et al.: HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation. Nature 2019; 568: 244&#8211;8.","DOI":"10.1038\/s41586-019-1027-4"},{"key":"10.3238\/arztebl.m2022.0105_ref46","doi-asserted-by":"crossref","unstructured":"Sveinbjornsson G, Gudbjartsson DF, Halldorsson BV, et al.: HLA class II sequence variants influence tuberculosis risk in populations of European ancestry. Nat Genet 2016; 48: 318&#8211;22.","DOI":"10.1038\/ng.3498"},{"key":"10.3238\/arztebl.m2022.0105_ref47","doi-asserted-by":"crossref","unstructured":"Wang Z, Sun Y, Fu X, et al.: A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy. Nat Commun 2016; 7: 13760.","DOI":"10.1038\/ncomms13760"},{"key":"10.3238\/arztebl.m2022.0105_ref48","doi-asserted-by":"crossref","unstructured":"Pairo-Castineira E, Clohisey S, Klaric L, et al.: Genetic mechanisms of critical illness in COVID-19. Nature 2021; 591: 92&#8211;8.","DOI":"10.1038\/s41586-020-03065-y"},{"key":"10.3238\/arztebl.m2022.0105_ref49","unstructured":"Fallerini C, Daga S, Mantovani S, et al.: Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study. Elife 2021; 10."},{"key":"10.3238\/arztebl.m2022.0105_ref50","doi-asserted-by":"crossref","unstructured":"Bjornevik K, Cortese M, Healy BC, et al.: Longitudinal analysis reveals high prevalence of Epstein-Barr virus. Science 2022; 375: 296&#8211;301.","DOI":"10.1126\/science.abj8222"},{"key":"10.3238\/arztebl.m2022.0105_ref51","doi-asserted-by":"crossref","unstructured":"Zacher B, Haller S, Willrich N, et al.: Application of a new methodology and R package reveals a high burden of healthcare-associated infections (HAI) in Germany compared to the average in the European Union\/European Economic Area, 2011 to 2012. Euro Surveill 2019; 24.","DOI":"10.2807\/1560-7917.ES.2019.24.46.1900135"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T09:34:48Z","timestamp":1645004088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":51,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0105","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}